Skip to main content

Client News

iOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business Officer

5th September 2023

InflaRx’s Marketing Authorization Application (MAA) for Vilobelimab for Treatment of Critically Ill COVID-19 Patients under Review by European Medicines Agency (EMA)

30th August 2023

Abivax Appoints Patrick Malloy as Senior Vice President Investor Relations

23rd August 2023

AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of PREVYMIS® (letermovir) in Second Indication

23rd August 2023

Medigene AG Expands Intellectual Property Rights for its Costimulatory Switch Proteins to Additional Immune Cell Types

23rd August 2023

Rentschler Biopharma, Cell and Gene Therapy Catapult and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapies

23rd August 2023

Destiny Pharma: Notice of Interim Results

23rd August 2023

ViGeneron Announces EMA Approval of Clinical Trial Application for VG901, a Gene Therapy to Treat Retinitis Pigmentosa

22nd August 2023

Mainz Biomed Announces Live Launch of ColoAlert® with testDNA Laboratory in Poland

22nd August 2023

Abivax secures up to EUR 150m from two structured debt financing transactions

22nd August 2023